SMO ClinPlus CO.,LTD.

SZSE:301257 Stock Report

Market Cap: CN¥2.8b

SMO ClinPlusLTD Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.2yrs

Recent management updates

Recent updates


CEO

SMO ClinPlusLTD has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Hongwei Yang
Director and General Managerno datano data7.36%
CN¥ 203.0m
Chunbao Lai
Chairman of the Boardno datano data5.85%
CN¥ 161.3m
Xiansheng Liao
Independent Director1.2yrsno datano data
Ranting Qian
Non-Independent Director1.2yrsno datano data
Deyong Qin
Supervisor1.2yrsno datano data
Lin Ma
Non-Independent Director1.2yrsno data0.00033%
CN¥ 9.1k
Yuping Ma
Supervisor1.2yrsno datano data
Xiaorong Fan
Non-Independent Director1.2yrsno datano data
Xiaolong Lai
Non-Independent Director1.2yrsno datano data
Xue Liu
Independent Director1.2yrsno datano data
Huasheng Huang
Independent Director1.2yrsno datano data

1.2yrs

Average Tenure

47yo

Average Age

Experienced Board: 301257's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.